MARATTO

article · Benha Medical Journal

Serum IgE level in children with Idiopathic Nephrotic Syndrome

2024Open accessBenha University

Abstract

Background: Nephrotic syndrome (NS) is one of the commonest chronic renal diseases in children, characterized by selective proteinuria, hypoalbuminemia, hyperlipidemia, and edema. This study aimed to assess the level of serum immune globulin (E) in children with idiopathic nephrotic syndrome as marker for prognosis of therapy. Methods: This prospective study was conducted in the pediatric department, Benha University Hospital. The study consisted of two groups: Group I: Fifty children suffering from idiopathic nephrotic syndrome treated with corticosteroid. Group II: Fifteen healthy children as a control group. All included children were subjected to full history taking, complete clinical examination, and laboratory assessment as complete blood count (CBC), absolute eosinophilic count, serum urea & creatinine, serum level of IgE, electrolytes, and 24 h protein in urine. Results: About three-quarters of group I were steroid sensitive (72.0%), and one-quarter were steroid-resistant (28.0%), Median serum IgE was significantly higher in group I (275.55) than group II (100.5), P= 0.001. Median serum IgE was significantly higher in the steroid-resistant group (911.85) than the steroid-sensitive (164.5), p=0.001. Roc analysis was done for differentiating between nephrotic patients and controls. For IgE, it revealed a significant area under curve (AUC) of 0.788. Conclusion: A significantly higher serum IgE levels were associated with Nephrotic syndrome and more prominently in patients with steroid-resistant nephrotic syndrome (SRNS).

Research topics

  • Renal Diseases and Glomerulopathies
  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bmfj.2024.115274.1526

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.